Integrated BioPharmaINBP 
$0.22-4.35%24h
-4.35%24h
Global rank33865
Market cap$6.59M
Change 7d-4.35%
YTD Performance-12.00%
SP500 benchmarkUnderperform
P/E-193.83
P/S0.13
Revenue$50.67M
Earnings-$34.00K
Dividend yield-
Main Sector
Consumer Defensive
Category
Integrated BioPharma INBP Total Debt
INBP Total Debt in 2022: $1.74M
According to Integrated BioPharma latest financial reports the total debt is $1.74M, an increase of 23.37% to 2022. At the end of 2022 company had $1.41M total debt. This figure represents the debts and financial obligations that Integrated BioPharma combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Integrated BioPharma INBP Total Debt History from 2023 to 2022
-
Value:-
INBP Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $1.74M | 23.37% |
| 2022 | $1.41M | -24.49% |
| 2021 | $1.87M | -50.50% |
| 2020 | $3.78M | -31.85% |
| 2019 | $5.54M | - |
View the Top Total Debt Stocks 
